{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:41:31Z","timestamp":1773661291976,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.transci.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T13:56:53Z","timestamp":1524146213000},"page":"291-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on \u03b1 and \u03b2 forms"],"prefix":"10.1016","volume":"57","author":[{"given":"Jean","family":"Amiral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerard","family":"Seghatchian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2018.04.010_bib0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.90.2345.539","article-title":"Heparin and blood clotting","volume":"90","author":"Brinkhous","year":"1939","journal-title":"Science"},{"issue":"July (2324)","key":"10.1016\/j.transci.2018.04.010_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.90.2324.36","article-title":"Heparin and the inhibition of blood-clotting","volume":"90","author":"Astrup","year":"1939","journal-title":"Science"},{"issue":"January (1)","key":"10.1016\/j.transci.2018.04.010_bib0015","first-page":"97","article-title":"An antithrombin reaction to prothrombin activation","volume":"176","author":"Seegers","year":"1954","journal-title":"Am J Physiol"},{"issue":"June (13)","key":"10.1016\/j.transci.2018.04.010_bib0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0038-1656297","article-title":"Inherited antithrombin deficiency causing thrombophilia","volume":"15","author":"Egeberg","year":"1965","journal-title":"Thromb Diath Haemorrh"},{"issue":"October (16)","key":"10.1016\/j.transci.2018.04.010_bib0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJM196810172791603","article-title":"Changes in the blood coagulation system associated with septicemia","volume":"279","author":"Corrigan","year":"1968","journal-title":"N Engl J Med"},{"issue":"July (7)","key":"10.1016\/j.transci.2018.04.010_bib0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/jcp.26.7.532","article-title":"Antithrombin-3 deficiency in a Dutch family","volume":"26","author":"van der Meer","year":"1973","journal-title":"J Clin Pathol"},{"issue":"2\u20133","key":"10.1016\/j.transci.2018.04.010_bib0035","first-page":"127","article-title":"Antithrombin III: critical review of assay methods. Significance of variations in health and disease","volume":"7","author":"Odeg\u00e5rd","year":"1978","journal-title":"Haemostasis"},{"issue":"6","key":"10.1016\/j.transci.2018.04.010_bib0040","first-page":"363","article-title":"Molar antithrombin concentration in normal human plasma","volume":"13","author":"Conard","year":"1983","journal-title":"Haemostasis"},{"issue":"December (36)","key":"10.1016\/j.transci.2018.04.010_bib0045","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.1016\/S0021-9258(18)45385-9","article-title":"The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity","volume":"262","author":"Liu","year":"1987","journal-title":"J Biol Chem"},{"issue":"October (6344)","key":"10.1016\/j.transci.2018.04.010_bib0050","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/353576a0","article-title":"Mobile reactive centre of serpins and the control of thrombosis","volume":"353","author":"Carrell","year":"1991","journal-title":"Nature"},{"issue":"July (1)","key":"10.1016\/j.transci.2018.04.010_bib0055","first-page":"14","article-title":"The conformational basis of thrombosis","volume":"86","author":"Carrell","year":"2001","journal-title":"Thromb Haemost"},{"issue":"January (1)","key":"10.1016\/j.transci.2018.04.010_bib0060","first-page":"57","article-title":"Conformational Asn187Asp\/Lys antithrombin variants and thrombosis. Clinical and biological features in 13 new heterozygotes","volume":"93","author":"Picard","year":"2005","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.transci.2018.04.010_bib0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/cc1540","article-title":"Antithrombin III in patients admitted to intensive care units: a multicenter observational study","volume":"6","author":"Messori","year":"2002","journal-title":"Crit Care"},{"issue":"September (9)","key":"10.1016\/j.transci.2018.04.010_bib0070","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/1060028016651276","article-title":"Issues in the diagnosis and management of hereditary antithrombin deficiency","volume":"50","author":"Bauer","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"July (3)","key":"10.1016\/j.transci.2018.04.010_bib0075","first-page":"543","article-title":"Effect of various estrogen treatment schedules on antithrombin III levels","volume":"14","author":"Ambrus","year":"1976","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"July (1)","key":"10.1016\/j.transci.2018.04.010_bib0080","first-page":"134","article-title":"Effect of oral contraceptives on antithrombin III measurement","volume":"72","author":"Petersen","year":"1979","journal-title":"Am J Clin Pathol"},{"issue":"January (1)","key":"10.1016\/j.transci.2018.04.010_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"issue":"May (5)","key":"10.1016\/j.transci.2018.04.010_bib0090","first-page":"775","article-title":"The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial","volume":"85","author":"H\u00f8ibraaten","year":"2001","journal-title":"Thromb Haemost"},{"issue":"September (3)","key":"10.1016\/j.transci.2018.04.010_bib0095","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.thromres.2015.06.039","article-title":"A new method to quantify \u03b2-antithrombin glycoform in plasma reveals increased levels during the acute stroke event","volume":"136","author":"de la Morena-Barrio","year":"2015","journal-title":"Thromb Res"},{"issue":"January (1)","key":"10.1016\/j.transci.2018.04.010_bib0100","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0021-9258(18)89776-9","article-title":"Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding","volume":"260","author":"Peterson","year":"1985","journal-title":"J Biol Chem"},{"issue":"January (3)","key":"10.1016\/j.transci.2018.04.010_bib0105","first-page":"314","article-title":"Antithrombin III \"Northwick Park\": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity","volume":"53","author":"Howarth","year":"1985","journal-title":"Thromb Haemost"},{"issue":"January (3)","key":"10.1016\/j.transci.2018.04.010_bib0110","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0021-9258(17)36071-4","article-title":"Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity","volume":"261","author":"Chang","year":"1986","journal-title":"J Biol Chem"},{"issue":"May (5)","key":"10.1016\/j.transci.2018.04.010_bib0115","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood.V69.5.1275.1275","article-title":"Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His","volume":"69","author":"Owen","year":"1987","journal-title":"Blood"},{"issue":"June (1-2)","key":"10.1016\/j.transci.2018.04.010_bib0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-5793(90)81530-2","article-title":"Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding","volume":"266","author":"Borg","year":"1990","journal-title":"FEBS Lett"},{"issue":"June (6)","key":"10.1016\/j.transci.2018.04.010_bib0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/jcp.44.6.477","article-title":"Screening for heparin binding variants of antithrombin","volume":"44","author":"Harper","year":"1991","journal-title":"J Clin Pathol"},{"issue":"March (5)","key":"10.1016\/j.transci.2018.04.010_bib0130","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1182\/blood.V81.5.1300.1300","article-title":"Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis","volume":"81","author":"Okajima","year":"1993","journal-title":"Blood"},{"issue":"December (12)","key":"10.1016\/j.transci.2018.04.010_bib0135","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2003-05-1560","article-title":"Heparin-induced substrate behavior of antithrombin Cambridge II","volume":"102","author":"Mushunje","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transci.2018.04.010_bib0140","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/j.1538-7836.2004.01047.x","article-title":"Latent antithrombin and its detection, formation and turnover in the circulation","volume":"2","author":"Mushunje","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"July (1)","key":"10.1016\/j.transci.2018.04.010_bib0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2013.05.012","article-title":"Great discrepancy in antithrombin activity measured using five commercially available functional assays","volume":"132","author":"Javela","year":"2013","journal-title":"Thromb Res"},{"issue":"September (18)","key":"10.1016\/j.transci.2018.04.010_bib0150","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1016\/S0021-9258(19)43472-8","article-title":"The purification and mechanism of action of human antithrombin-heparin cofactor","volume":"248","author":"Rosenberg","year":"1973","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.transci.2018.04.010_bib0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0049-3848(74)90001-2","article-title":"Purification of antithrombin III by affinity chromatography","volume":"5","author":"Miller-Andersson","year":"1974","journal-title":"Thromb Res"},{"issue":"October (4)","key":"10.1016\/j.transci.2018.04.010_bib0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0049-3848(77)90208-0","article-title":"Antithrombin (heparin cofactor) assay with \"new\" chromogenic substrates (S-2238 and Chromozym TH)","volume":"11","author":"Abildgaard","year":"1977","journal-title":"Thromb Res"},{"issue":"March (3)","key":"10.1016\/j.transci.2018.04.010_bib0165","first-page":"231","article-title":"An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition","volume":"69","author":"Demers","year":"1993","journal-title":"Thromb Haemost"},{"issue":"July (1)","key":"10.1016\/j.transci.2018.04.010_bib0170","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2353\/ajpath.2006.051238","article-title":"L-Asparaginase-induced antithrombin type I deficiency: implications for conformational diseases","volume":"169","author":"Hern\u00e1ndez-Espinosa","year":"2006","journal-title":"Am J Pathol"},{"issue":"November (6)","key":"10.1016\/j.transci.2018.04.010_bib0175","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"issue":"May (9)","key":"10.1016\/j.transci.2018.04.010_bib0180","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/sj.emboj.7601089","article-title":"Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation","volume":"25","author":"Johnson","year":"2006","journal-title":"EMBO J"},{"issue":"May\u2013June (3)","key":"10.1016\/j.transci.2018.04.010_bib0185","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/01.ATV.11.3.530","article-title":"Antithrombin III-beta associates more readily than antithrombin III-alpha with uninjured and de-endothelialized aortic wall in vitro and in vivo","volume":"11","author":"Witmer","year":"1991","journal-title":"Arterioscler Thromb"},{"issue":"October (10)","key":"10.1016\/j.transci.2018.04.010_bib0190","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1161\/01.ATV.16.10.1292","article-title":"Thrombin inhibition by antithrombin III on the subendothelium is explained by the isoform AT beta","volume":"16","author":"Frebelius","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"October (10)","key":"10.1016\/j.transci.2018.04.010_bib0195","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/jth.12364","article-title":"Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture","volume":"11","author":"Puurunen","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"July (7)","key":"10.1016\/j.transci.2018.04.010_bib0200","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jth.12597","article-title":"Beta (\u03b2)-antithrombin activity in children and adults: implications for heparin therapy in infants and children","volume":"12","author":"Karlaftis","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"April (4)","key":"10.1016\/j.transci.2018.04.010_bib0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00134-016-4225-7","article-title":"Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis","volume":"42","author":"Allingstrup","year":"2016","journal-title":"Intensive Care Med"},{"issue":"September (5435)","key":"10.1016\/j.transci.2018.04.010_bib0210","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1126\/science.285.5435.1926","article-title":"Antiangiogenic activity of the cleaved conformation of the serpin antithrombin","volume":"285","author":"O\u2019Reilly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.transci.2018.04.010_bib0215","first-page":"9261351","article-title":"Management of venous thromboembolism in patients with hereditary antithrombin deficiency and pregnancy: case report and review of the literature","volume":"2017","author":"Refaei","year":"2017","journal-title":"Case Rep Hematol"},{"issue":"February (2)","key":"10.1016\/j.transci.2018.04.010_bib0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2141.1986.tb02941.x","article-title":"An association between the factor VII coagulant activity and thrombin activity induced by surface\/cold exposure of normal human plasma","volume":"62","author":"Miller","year":"1986","journal-title":"Br J Haematol"},{"issue":"January (1)","key":"10.1016\/j.transci.2018.04.010_bib0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2141.2010.08432.x","article-title":"Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin","volume":"152","author":"Petersen","year":"2011","journal-title":"Br J Haematol"},{"issue":"October (2)","key":"10.1016\/j.transci.2018.04.010_bib0230","first-page":"176","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb Haemost"},{"issue":"February (2)","key":"10.1016\/j.transci.2018.04.010_bib0235","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jth.13198","article-title":"Identification and function probing of an antithrombin III\u03b2 conformation-specific antibody","volume":"14","author":"Jin","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"December (6)","key":"10.1016\/j.transci.2018.04.010_bib0240","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.transci.2017.11.021","article-title":"Laboratory assessment of activated protein C resistance\/factor V-Leiden and performance characteristics of a new quantitative assay","volume":"56","author":"Amiral","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"December (12)","key":"10.1016\/j.transci.2018.04.010_bib0245","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajh.21893","article-title":"Laboratory tests for antithrombin deficiency","volume":"85","author":"Khor","year":"2010","journal-title":"Am J Hematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218301289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218301289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T08:09:34Z","timestamp":1660982974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050218301289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1473050218301289"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2018.04.010","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on \u03b1 and \u03b2 forms","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}